 |
 |
Cancer Research Studies
Breast Cancer Treatment Trials
Breast Cancer Treatment Trials
 |
Learn more. |
Study Title:
The TAILORx Trial: Program for the Assessment
of Clinical Cancer Tests (PACCT-1) Trials Assigning Individualized
Options for Treatment
|
Learn more. |
Study Title:
Post Market Clinical Study to Evaluate
the Safety and Performance of the Axxent TM Electronic Brachytherapy
System in Women with Resected, Early Stage Breast Cancer
|
Learn more. |
Study Title:
NSABP-B-39 A Randomized Phase III Study
of Conventional Whole Breast Irradiation (WBI) Versus Partial Breast
Irradiation (PBI) for Women with Stage 0, I or II Breast Cancer
Study Title: Program for the Assessment of Clinical Cancer Tests (PACCT-1) Trials Assigning Individualized Options for Treatment: The TAILORx Trial
What is the purpose of this study?
This study is designed to determine which patients
with early stage breast cancer would be more likely to benefit from chemotherapy
and reduce the use of chemotherapy in those who are unlikely to
benefit from it.
Am I a candidate for this trial?
In order to be a candidate for this trial:
- You must be 18 to 75 years old.
- Your tumor was estrogen and progesterone receptor positive.
- Your tumor was Her2/neu negative.
- Your lymph nodes were disease free.
Why should I participate?
- TAILORx is studying how to predict the best treatment options based on the genetic makeup of your tumor.
- Your treatment will be tailored to you.
- Your treatment may be the best treatment available.
What do I need to do?
- Ask your physician/surgeon to order a test called Oncotype DX.
- The test will calculate a risk for recurrence score based on the genetic makeup of your tumor.
- You must agree to be randomized to a treatment arm that may or may not use chemotherapy in combination with hormone therapy.
If you are interested in this breast cancer research study, please
contact:
Kristin Sorensen, MS, RN, research nurse
sorenk@holycrosshealth.org
301.754.7961
Principle Investigator: Cheryl Aylesworth, MD, medical oncologist
Study Title: Post Market Clinical Study to Evaluate the Safety and Performance of the Axxent TM Electronic Brachytherapy System in Women with Resected, Early Stage Breast Cancer
What is the purpose of the study?
The Axxent Electronic Brachytherapy System study is investigating the
safety and effectiveness of an innovative form of radiation therapy
as part of breast conserving therapy in women with resected, early stage
breast cancer.
Am I a candidate for this trial?
- Are you at least 50 years old?
- Were you diagnosed with Ductal Carcinoma In Situ (DCIS) or Invasive Ductal Carcinoma (IDC)?
What do I need to do?
- You must agree to undergo a new form of radiation therapy.
- You must agree to have two treatments per day for five consecutive days.
- You must have follow up visits at one week, four weeks, three months and six months post treatment.
- You must complete several brief questionnaires.
Why should I participate?
- You may receive the best treatment available.
- Your time and schedule commitment is significantly less than that of standard radiation therapy (days versus weeks).
If you are interested in this breast cancer research study, please
contact:
Pearl Samuel, MBBS, research assistant
301.754.8437
Samuepe@holycrosshealth.org
Principal investigator: Sheela Modin, MD, radiation oncologist
Study Title: NSABP-B-39 A Randomized Phase III Study of Conventional Whole Breast Irradiation (WBI) Versus Partial Breast Irradiation (PBI) for Women with Stage 0, I or II Breast Cancer
What is the purpose of the study?
The purpose of this study is to determine whether partial breast irradiation
is as effective as whole breast irradiation in early stage breast cancers.
Am I a candidate for this study?
- Are you at least 18 years old?
- Have you been diagnosed with Ductal Carcinoma In Situ (DCIS) or Invasive Ductal Carcinoma?
- Did you have less than three positive nodes?
What do I need to do?
- Agree to be randomized to partial versus whole breast irradiation.
- Give researchers permission to obtain your blood.
- Answer questions related to your experience.
- Adhere to a physician visit schedule and follow up by researchers.
Why should I participate?
By participating, you are helping to determine whether partial breast
irradiation is as effective or better than whole breast irradiation.
If you are interested in this breast cancer research study, please
contact:
Pearl Samuel, MBBS, research assistant
301.754.8437
Samuepe@holycrosshealth.org
Principal Investigator: Sheela Modin, MD, radiation
oncologist
Co-Investigator: Heather Lee, MD, radiation oncologist
About Our Program
Prevention & Early Detection
Studies
Treatment Studies
Survivor Studies
Related Information